| Literature DB >> 31261470 |
Abstract
The modalities currently employed to screen for type 2 diabetes mellitus (T2DM)/prediabetes are HbA1c, fasting plasma glucose (FPG), and 2-hour plasma glucose (PG) during an oral glucose tolerance test (OGTT). The purpose of this review is to highlight the positive qualities and pitfalls of these diagnostic modalities and reflect on the most reasonable and effective approach to screen high risk youth. Given its inherent preanalytical advantages, glycated hemoglobin (HbA1c) continues to be the preferred diagnostic modality used by pediatricians to screen high risk youth. However, when the three aforementioned tests are performed in youths of different races/ethnicities, discrepant results for T2DM/prediabetes are observed. The prevalence rates for T2DM vary from 0.53% in Chinese youth (including youth of all body mass indexes) to 18.3% in high-risk, overweight, obese Korean youth. Moreover, the FPG is abnormal (>100 less than <126 mg/dL) in 15% of Korean youth versus 8.7% of Chinese youth. The prevalence rates for prediabetes are 1.49% in Chinese youth versus 21% in Emirati youth (HbA1c, 5.7%-6.4%). The coefficient of agreement, k, between these screening tests for T2DM are fair, 0.45-0.5 across all youth. However, using HbA1c as a comparator, the agreement is weak with FPG (k=0.18 in German youth versus k=0.396 in Korean youth). The American Diabetes Association (ADA) Standards of Medical Care Guidelines define "high risk youth" who need to be tested for T2DM and/or prediabetes. OGTT and HbA1c do not always detect T2DM in similar individuals. HbA1c may not be an ideal test for screening Hispanic and African American youth. FPG and OGTT are suitable screening tests for youth of ethnic minorities and those with cystic fibrosis or hemoglobinopathies. Performing all three tests either together or sequentially may be the only way to encompass all youth who have aberrations in different aspects of glucose homeostasis.Entities:
Keywords: Fasting plasma glucose; Glycated hemoglobin A; Oral glucose tolerance test; Prediabetic state; Screening tests; Youth; Type 2 diabetes mellitus
Year: 2019 PMID: 31261470 PMCID: PMC6603607 DOI: 10.6065/apem.2019.24.2.71
Source DB: PubMed Journal: Ann Pediatr Endocrinol Metab ISSN: 2287-1012
Categories of increased risk for diabetes (prediabetes)[*]
| FPG 100 mg/dL (5.6 mmol/L) to 125 mg/dL (6.9 mmol/L) (IFG) |
| OR |
| 2-hr PG during 75-g OGTT 140 mg/dL (7.8 mmol/L) to 199 mg/dL (11.0 mmol/L) (IGT) |
| OR |
| A1c 5.7%–6.4% (39–47 mmol/mol) |
FPG, fasting plasma glucose; PG, plasma glucose; IFG, impaired fasting glucose; OGTT, oral glucose tolerance test; IGT, impaired glucose tolerance.
For all 3 tests, risk is continuous, extending below the lower limit of the range and becoming disproportionately greater at the higher end of the range.
Adapted from American Diabetes Association. Diabetes Care 2019;42(Suppl 1):S13-28.[1]
Risk-based screening for type 2 diabetes or prediabetes in asymptomatic children and adolescents in a clinical setting[*]
| Plus one or more additional risk factors based on the strength of their association with diabetes as indicated by evidence grades: |
| • Maternal history of diabetes or gestational diabetes mellitus during the child's gestation |
| • Family history of type 2 diabetes in first- or second-degree relative |
| • Race/ethnicity (Native American, African American, Latino, Asian American, Pacific Islander) |
| • Signs of insulin resistance or conditions associated with insulin resistance (acanthosis nigricans, hypertension, dyslipidemia, polycystic ovary syndrome, or small-for-gestational-age birth weight) |
Criteria: overweight (body mass index>85th percentile for age and sex, weight for height >85th percentile, or weight >120% of ideal for height)
Age less than 18 years.
Adapted from Arslanian S, et al. Diabetes Care 2018;41:2648-68.[8]
Demographic data and screening tests for prediabetes in five relevant studies
| Author | Average HbA1c[ | Race | Age (yr) | Weight[ | Male sex (%) | BMI | FBG | HbA1c | OGTT | Combined (FPG+ HbA1c+ 2-hr PG | K-coefficient of agreement | Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yang et al. [ | 7,519 | Chinese | 6–17 | 5823-N/896-OW/437- OB | 55 | 8.72%† (CI, 8–9.36) | 1.49%† (CI, 1.22–1.77) | Not done | 9.8% CI† (9.13–10.47) | Higher rates males vs. females | ||
| †FPG=1.9 vs. 0.9; P=0.001 | ||||||||||||
| †HbA1c=9.1 vs. 8.3; P=0.2 | ||||||||||||
| Al Amiri et al. [ | 1,034 | United Arab Emirates | 14.7 | 228-OW/806-OB | 58 | 2.1 (1.8–2.4) | NA | 12.1%† | NA | 5.4%† | Concordance between HbA1c and FPG=11% | |
| Nam et al. [ | 389 | Korean | 13+2.5 | 48-OW/314-OB | 55 | 2.3+0.6 | 15%† (n=61) | 20%† (n=81) | 31.1%† (n=121) | k[ | 9.4% fulfilled all criteria-FPG+HbA1c+2-hr PG | |
| 2-hr PG=7.9+1 mmol/L | k=0.396 (0.356–0.46) FPG | 11% would have missed Without OGTT | ||||||||||
| k=0.47(0.46–0.500) 2-hr PG | ||||||||||||
| Khokhar et al. [ | 230 | Caribbean/African-American (83% of cohort) | 13.5+2.8 | 230-OW/OB | 43 | 2.30+0.40 | 91+13.6 mg/dL | 56%† (n=129); HbA1c=5.7%±0.5% | 25%† (n=60) | 18%† (n=42) had prediabetes | ||
| 2-hr PG=113±30 mg/dL | ||||||||||||
| Ehehalt et al. [ | 4,848 | German | 13+2.4 | 759-OW/4090- OB | 45 | 2.8 0.6 | 9%† (n=436); 103 mg/dL; IQR, 101–103 | 23%† (n=1,143); 5.8% (IQR, 5.7%–6%) | 12%† (n=599); 149 mg/dL; IQR, 144–161) | k[ | 1-Point increase in HbA1c=2.5-4 mg/dL ↑ in FPG=6-9 mg/dL ↑ in 2-hr PG | |
| k=0.17 for 2-hr PG | ||||||||||||
| K=0.21 FPG+2-hr PG |
FPG=(ADA criteria=5.6–6.9 mmol/L or >100 mg/dL or less <126 mg/dL); HbA1c=5.7% to 6.4% (38.8 to 46.5 mmol/mol); (2-hr plasma glucose [PG] challenge)=7.8–11.0 mmol/L or >140 but <200 mgl/dL.
FPG, fasting plasma glucose; ADA, American Diabetes Association; HbA1c, glycosylated hemoglobin; IQR, interquartile range; BMI, body mass index; CI, confidence interval; OW, overweight; OB, obese; NA, normal; IFG, impaired fasting glucose; OGTT, oral glucose tolerance test; IGT, impaired glucose tolerance.
Normal N/overweight-OW/obese-OB. †Prevalence rate for prediabetes in the studies.
k coefficient was used HbA1c as comparator.
k coefficient used HbA1c as comparator but all values were log transformed.
Average HbA1c in the prediabetes grp=5.8+ 0.8. HbA1c of 5.8% had a sensitivity of 64% and specificity of 84% with area under the curve of 0.795.
Conversion to SI units: A1c (mmol/mol)=10.93×A1c (%)–23.95.